Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on January 13, 2003

Hypertension. 2003
Published online before print January 13, 2003, doi: 10.1161/01.HYP.0000051890.68573.94
A more recent version of this article appeared on March 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
41/3/730    most recent
01.HYP.0000051890.68573.94v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garg, R.
Right arrow Articles by Pandey, K. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garg, R.
Right arrow Articles by Pandey, K. N.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Genetics of cardiovascular disease

Submitted on September 19, 2002
Revised on October 25, 2002

Angiotensin II-Mediated Negative Regulation of Npr1 Promoter Activity and Gene Transcription

Renu Garg and Kailash N. Pandey*

From the Department of Physiology and Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center and School of Medicine, New Orleans, La.

* To whom correspondence should be addressed. E-mail: kpandey{at}tulane.edu.

Abstract--Atrial natriuretic peptide receptor A (NPRA) plays important role(s) in the control of extracellular fluid volume and blood pressure homeostasis. We have determined and analyzed the functional promoter region of Npr1 gene (coding for NPRA) and studied the effect of angiotensin (Ang) II on its promoter activity and expression in cultured mouse mesangial cells. The promoter analysis of Npr1 gene revealed the presence of positive regulatory cis-elements in the regions -1982 to -1841 bp and -916 to -496 bp and of the repressor elements in the regions -1841 to -916 bp and 56 to 382 bp relative to transcription start site. The Ang II pretreatment of cultured mouse mesangial cells transiently transfected with the promoter construct pNPRA-luc1 significantly inhibited the promoter activity in a time- and dose-dependent manner, with a maximum inhibition at 24 hours. The Ang II-dependent repression of Npr1 promoter activity was partially blocked by both angiotensin type 1 and type 2 antagonists candesartan and PD 123,319, respectively. The mRNA level of NPRA was also downregulated by Ang II treatment as determined by semiquantitative reverse transcriptase-polymerase chain reaction assay. The deletion analysis showed that the promoter region {approx}916 bp upstream of transcription start site contains the cis-elements involved in Ang II-mediated repression of transcription of Npr1 gene. The present study thus reveals the presence of functional cis-regulatory elements in the promoter region of the murine Npr1 gene and its transcriptional downregulation by vasoactive peptide Ang II.


Key words: natriuretic peptide receptor • angiotensin II • gene transcription • promoter analysis • gene expression • mesangial cells




This article has been cited by other articles:


Home page
HypertensionHome page
P. Kumar and K. N. Pandey
Cooperative Activation of Npr1 Gene Transcription and Expression by Interaction of Ets-1 and p300
Hypertension, July 1, 2009; 54(1): 172 - 178.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
E. Vellaichamy, D. Zhao, N. Somanna, and K. N. Pandey
Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy
Physiol Genomics, October 19, 2007; 31(2): 193 - 202.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. G. Gardner, S. Chen, D. J. Glenn, and C. L. Grigsby
Molecular Biology of the Natriuretic Peptide System: Implications for Physiology and Hypertension
Hypertension, March 1, 2007; 49(3): 419 - 426.
[Full Text] [PDF]


Home page
EndocrinologyHome page
D. Rahmutula and D. G. Gardner
C-Type Natriuretic Peptide Down-Regulates Expression of Its Cognate Receptor in Rat Aortic Smooth Muscle Cells
Endocrinology, November 1, 2005; 146(11): 4968 - 4974.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. Rahmutula, J. Cui, S. Chen, and D. G. Gardner
Transcriptional Regulation of Type B Human Natriuretic Peptide Receptor Gene Promoter: Dependence on Sp1
Hypertension, September 1, 2004; 44(3): 283 - 288.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. Hum, S. Besnard, R. Sanchez, D. Devost, F. Gossard, P. Hamet, and J. Tremblay
Characterization of a cGMP-Response Element in the Guanylyl Cyclase/Natriuretic Peptide Receptor A Gene Promoter
Hypertension, June 1, 2004; 43(6): 1270 - 1278.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Kuhn
Structure, Regulation, and Function of Mammalian Membrane Guanylyl Cyclase Receptors, With a Focus on Guanylyl Cyclase-A
Circ. Res., October 17, 2003; 93(8): 700 - 709.
[Abstract] [Full Text] [PDF]